These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36434425)

  • 1. Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review.
    Mital R; Gray A; Minta A; Almhana F; Amin S; Hydol-Smith J; Mallela T; Kaffenberger BH
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):77-94. PubMed ID: 36434425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.
    Huang J; Tsang LS; Shi W; Li J
    Front Med (Lausanne); 2022; 9():856786. PubMed ID: 35402426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review.
    Yamanaka K
    J Dermatol; 2024 Feb; 51(2):172-179. PubMed ID: 38009911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders.
    Garcovich S; De Simone C; Genovese G; Berti E; Cugno M; Marzano AV
    Front Pharmacol; 2019; 10():282. PubMed ID: 30971924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anakinra in Pyogenic Arthritis, Acne, Pyoderma Gangrenosum, and Suppurative Hidradenitis (PAPASH) Spectrum Disorder: A Case Report and Literature Review.
    Ahmad A; Moore T
    Cureus; 2024 Jun; 16(6):e62247. PubMed ID: 39006661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
    Vinkel C; Thomsen SF
    Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label dermatologic uses of IL-17 inhibitors.
    Wu KK; Dao H
    J Dermatolog Treat; 2022 Feb; 33(1):41-47. PubMed ID: 32116066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis suppurativa and vasculitis: A case series and literature review of a rare association.
    Alavi A; Shavit E; Archer J; Pagnoux C
    SAGE Open Med Case Rep; 2019; 7():2050313X19882852. PubMed ID: 31673357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.
    Sun NZ; Ro T; Jolly P; Sayed CJ
    J Clin Aesthet Dermatol; 2017 Sep; 10(9):36-38. PubMed ID: 29344326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis.
    Zhou Q; Zhou S; Xiong H; Yang J; Yang Z; Zhou N; Mao J; Li M
    Clin Cosmet Investig Dermatol; 2023; 16():1493-1497. PubMed ID: 37333515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion.
    Turcu G; Ioana Nedelcu R; Teodora Nedelcu I; Hodorogea A; Balaban M; Brinzea A; Nichita L; Gabriela Popp C; Andrada Zurac S; Theodor Andrei R
    Exp Ther Med; 2020 Jul; 20(1):38-41. PubMed ID: 32508990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning From Success and Failure: Biologics for Non-approved Skin Diseases.
    Speeckaert R; Lambert J; van Geel N
    Front Immunol; 2019; 10():1918. PubMed ID: 31440261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa and psoriasis: the odd couple.
    Macca L; Li Pomi F; Ingrasciotta Y; Morrone P; Trifirò G; Guarneri C
    Front Med (Lausanne); 2023; 10():1208817. PubMed ID: 37484864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Exploration of Alternate Immune Pathways Needed in Hidradenitis Suppurativa? A Case of Atopic Dermatitis and Concurrent Hidradenitis Suppurativa Responding to Dupilumab.
    McCormack S; Tazudeen N; Garden BC
    Case Rep Dermatol Med; 2023; 2023():5189034. PubMed ID: 37908412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
    Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
    Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.
    Rawal S; Kianian S; Guo W; Marquez J; Ayasse M; Siamas KA; Lee Y; Salvemini J
    Arch Dermatol Res; 2022 Aug; 314(6):503-514. PubMed ID: 34156549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
    Scheinfeld N
    Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Alterations and Metabolism Disturbances in Selected Inflammatory Skin Diseases.
    Nowowiejska J; Baran A; Flisiak I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
    Marzano AV; Damiani G; Ceccherini I; Berti E; Gattorno M; Cugno M
    Br J Dermatol; 2017 Jun; 176(6):1588-1598. PubMed ID: 27943240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.
    Ruggiero A; Martora F; Picone V; Marano L; Fabbrocini G; Marasca C
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.